Bausch Health
BHC
S$8.86
Share price
1.77%
Change (1 day)
10.89%
Change (1 year)
Categories
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.
Bausch Health (BHC) - Cash on Hand
Cash on Hand as of March 2025 : S$1.45 Billion
According to Bausch Health
's latest financial reports the company has S$1.45 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Bausch Health - Cash on Hand chart (from 1996 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | S$1.60 B | 28.35% |
| 2023-12-31 | S$1.25 B | 65.42% |
| 2022-12-31 | S$0.75 B | -3.9% |
| 2021-12-31 | S$0.78 B | -1.7% |
| 2020-12-31 | S$0.80 B | -81.69% |
| 2019-12-31 | S$4.37 B | 343.88% |
| 2018-12-31 | S$0.98 B | 2.28% |
| 2017-12-31 | S$0.96 B | 22.76% |
| 2016-12-31 | S$0.78 B | -7.11% |
| 2015-12-31 | S$0.84 B | 98.11% |
| 2014-12-31 | S$0.42 B | -43.95% |
| 2013-12-31 | S$0.76 B | -32.11% |
| 2012-12-31 | S$1.12 B | 407.51% |
| 2011-12-31 | S$0.22 B | -57.2% |
| 2010-12-31 | S$0.51 B | 196.17% |
| 2009-12-31 | S$0.17 B | -61.74% |
| 2008-12-31 | S$0.45 B | -27.71% |
| 2007-12-31 | S$0.62 B | -50.8% |
| 2006-12-31 | S$1.27 B | 72.41% |
| 2005-12-31 | S$0.74 B | 1056.5% |
| 2004-12-31 | S$64.17 M | -71.65% |
| 2003-12-31 | S$0.22 B | 132.68% |
| 2002-12-31 | S$97.3 M | -87.91% |
| 2001-12-31 | S$0.80 B | 271.18% |
| 2000-12-31 | S$0.21 B | -46.61% |
| 1999-12-31 | S$0.40 B | 214.24% |
| 1998-12-31 | S$0.12 B | 823.79% |
| 1997-12-31 | S$13.99 M | 122.2% |
| 1996-12-31 | S$6.29 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Onconova Therapeutics ONTX | S$21.07 M | -98.55% | 🇺🇸 USA |
 OPKO Health
OPK | S$0.56 B | -61.55% | 🇺🇸 USA |